Free Trial

Surgery Partners (SGRY) Competitors

Surgery Partners logo
$22.51 -0.24 (-1.05%)
(As of 11/20/2024 ET)

SGRY vs. HIMS, SHC, GH, OPCH, BTSG, VCYT, LFST, CON, PACS, and PRVA

Should you be buying Surgery Partners stock or one of its competitors? The main competitors of Surgery Partners include Hims & Hers Health (HIMS), Sotera Health (SHC), Guardant Health (GH), Option Care Health (OPCH), BrightSpring Health Services (BTSG), Veracyte (VCYT), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), PACS Group (PACS), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry.

Surgery Partners vs.

Hims & Hers Health (NYSE:HIMS) and Surgery Partners (NASDAQ:SGRY) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation, profitability and media sentiment.

In the previous week, Hims & Hers Health had 19 more articles in the media than Surgery Partners. MarketBeat recorded 32 mentions for Hims & Hers Health and 13 mentions for Surgery Partners. Surgery Partners' average media sentiment score of 0.49 beat Hims & Hers Health's score of 0.26 indicating that Surgery Partners is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
9 Very Positive mention(s)
7 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Surgery Partners
7 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Hims & Hers Health has a net margin of 8.19% compared to Surgery Partners' net margin of -2.03%. Hims & Hers Health's return on equity of 10.97% beat Surgery Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health8.19% 10.97% 8.29%
Surgery Partners -2.03%2.85%1.22%

Hims & Hers Health presently has a consensus target price of $20.71, indicating a potential downside of 4.98%. Surgery Partners has a consensus target price of $38.71, indicating a potential upside of 71.99%. Given Surgery Partners' stronger consensus rating and higher possible upside, analysts plainly believe Surgery Partners is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
1 Sell rating(s)
8 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.38
Surgery Partners
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75

Hims & Hers Health has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500. Comparatively, Surgery Partners has a beta of 2.76, indicating that its stock price is 176% more volatile than the S&P 500.

63.5% of Hims & Hers Health shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by insiders. Comparatively, 2.3% of Surgery Partners shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Surgery Partners received 273 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 57.62% of users gave Surgery Partners an outperform vote while only 37.37% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
Hims & Hers HealthOutperform Votes
37
37.37%
Underperform Votes
62
62.63%
Surgery PartnersOutperform Votes
310
57.62%
Underperform Votes
228
42.38%

Surgery Partners has higher revenue and earnings than Hims & Hers Health. Surgery Partners is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$872M5.46-$23.55M$0.4449.55
Surgery Partners$2.74B1.04-$11.90M-$0.48-46.90

Summary

Hims & Hers Health beats Surgery Partners on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SGRY vs. The Competition

MetricSurgery PartnersGeneral medical & surgical hospitals IndustryMedical SectorNASDAQ Exchange
Market Cap$2.89B$14.71B$5.05B$8.87B
Dividend YieldN/A0.59%4.97%4.06%
P/E Ratio-46.904.1297.3414.18
Price / Sales1.040.671,218.4289.42
Price / Cash12.677.5933.5132.79
Price / Book0.9218.005.805.12
Net Income-$11.90M$809.93M$119.07M$225.99M
7 Day Performance-9.12%-3.08%-1.83%-1.32%
1 Month Performance-29.39%-14.09%-3.64%0.60%
1 Year Performance-29.72%31.59%31.62%26.23%

Surgery Partners Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SGRY
Surgery Partners
3.0975 of 5 stars
$22.51
-1.1%
$38.71
+72.0%
-29.9%$2.89B$2.74B-46.9013,500Analyst Forecast
HIMS
Hims & Hers Health
3.5685 of 5 stars
$21.80
-7.4%
$20.71
-5.0%
+181.8%$5.14B$872M49.551,046Analyst Forecast
Insider Trade
SHC
Sotera Health
3.662 of 5 stars
$13.21
-2.9%
$16.50
+24.9%
-5.2%$3.85B$1.05B52.843,000High Trading Volume
GH
Guardant Health
4.2798 of 5 stars
$30.68
flat
$40.60
+32.3%
+28.4%$3.79B$563.95M0.001,779
OPCH
Option Care Health
4.9784 of 5 stars
$21.88
+0.3%
$30.83
+40.9%
-26.3%$3.71B$4.30B18.397,802Positive News
BTSG
BrightSpring Health Services
2.9593 of 5 stars
$18.79
+0.8%
$16.79
-10.6%
N/A$3.27B$10.59B-72.2735,000Positive News
VCYT
Veracyte
4.1264 of 5 stars
$39.20
+0.1%
$41.25
+5.2%
+50.5%$3.03B$361.05M-261.33790Analyst Forecast
LFST
LifeStance Health Group
1.7828 of 5 stars
$7.22
-0.3%
$8.50
+17.7%
+16.5%$2.77B$1.06B0.009,325
CON
Concentra Group Holdings Parent
N/A$21.27
+4.9%
$28.50
+34.0%
N/A$2.71B$1.84B0.0011,000Gap Up
High Trading Volume
PACS
PACS Group
4.0685 of 5 stars
$17.25
+0.9%
$39.88
+131.2%
N/A$2.61B$3.11B0.0032,433Analyst Forecast
PRVA
Privia Health Group
3.3446 of 5 stars
$20.79
-1.5%
$25.07
+20.6%
-9.2%$2.53B$1.66B207.921,102Positive News

Related Companies and Tools


This page (NASDAQ:SGRY) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners